• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：异鼠李素通过PI3K/AKT信号通路失活抑制人胆囊癌细胞增殖和转移。

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis PI3K/AKT Signaling Pathway Inactivation.

作者信息

Zhai Tianyu, Zhang Xiaoyu, Hei Zhenyu, Jin Longyang, Han Chao, Ko Audrey Tsznam, Yu Xiaofeng, Wang Jiandong

机构信息

Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Research Center of Biliary Tract Disease, Shanghai, China.

出版信息

Front Pharmacol. 2021 Oct 20;12:792330. doi: 10.3389/fphar.2021.792330. eCollection 2021.

DOI:10.3389/fphar.2021.792330
PMID:34744756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8564876/
Abstract

[This corrects the article DOI: 10.3389/fphar.2021.628621.].

摘要

[本文更正了文章DOI：10.3389/fphar.2021.628621。]

相似文献

1
Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis PI3K/AKT Signaling Pathway Inactivation.勘误：异鼠李素通过PI3K/AKT信号通路失活抑制人胆囊癌细胞增殖和转移。
Front Pharmacol. 2021 Oct 20;12:792330. doi: 10.3389/fphar.2021.792330. eCollection 2021.
2
Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation.异鼠李素通过PI3K/AKT信号通路失活抑制人胆囊癌细胞增殖和转移。
Front Pharmacol. 2021 Feb 17;12:628621. doi: 10.3389/fphar.2021.628621. eCollection 2021.
3
Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway.勘误：DT - 13通过阻断PI3K/Akt通路抑制人前列腺癌细胞的增殖和转移。
Front Pharmacol. 2020 Apr 8;11:462. doi: 10.3389/fphar.2020.00462. eCollection 2020.
4
Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway.勘误：肉桂醛通过PI3K/AKT途径抑制表皮生长因子诱导的上皮-间质转化过程并抑制卵巢癌进展。
Front Pharmacol. 2024 Jul 8;15:1427330. doi: 10.3389/fphar.2024.1427330. eCollection 2024.
5
Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.山奈酚通过靶向线粒体依赖性内在凋亡和 PI3K/Akt/mTOR 通路抑制雄激素非依赖性前列腺癌细胞的增殖和转移。
Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20192826.
6
Isorhamnetin Promotes Estrogen Biosynthesis and Proliferation in Porcine Granulosa Cells via the PI3K/Akt Signaling Pathway.异鼠李素通过PI3K/Akt信号通路促进猪颗粒细胞雌激素生物合成和增殖。
J Agric Food Chem. 2021 Jun 16;69(23):6535-6542. doi: 10.1021/acs.jafc.1c01543. Epub 2021 Jun 7.
7
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells.勘误：槲皮素通过下调急性髓系白血病细胞中VEGF/Akt信号通路诱导细胞凋亡。
Front Pharmacol. 2021 Feb 8;11:640750. doi: 10.3389/fphar.2020.640750. eCollection 2020.
8
Corrigendum: Xiaoyaosan alleviates hippocampal glutamate-induced toxicity in the CUMS rats via NR2B and PI3K/Akt signaling pathway.勘误：逍遥散通过NR2B和PI3K/Akt信号通路减轻慢性不可预知温和应激（CUMS）大鼠海马谷氨酸诱导的毒性。
Front Pharmacol. 2022 Dec 15;13:1042762. doi: 10.3389/fphar.2022.1042762. eCollection 2022.
9
Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway.勘误：人参皂苷Re通过调节PI3K/AKT抑制HIF-1α/VEGF信号通路减轻高糖诱导的RF/6A损伤
Front Pharmacol. 2020 Oct 23;11:1312. doi: 10.3389/fphar.2020.01312. eCollection 2020.
10
Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis Regulation of the PI3K/AKT/mTOR Signaling Pathway.勘误：扁柏黄酮通过诱导凋亡调节PI3K/AKT/mTOR信号通路抑制食管鳞状细胞癌生长。
Front Oncol. 2022 Jul 5;12:970020. doi: 10.3389/fonc.2022.970020. eCollection 2022.

引用本文的文献

1
Advances in Isorhamnetin Treatment of Malignant Tumors: Mechanisms and Applications.异鼠李素治疗恶性肿瘤的研究进展：作用机制与应用
Nutrients. 2025 May 29;17(11):1853. doi: 10.3390/nu17111853.
2
Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway.山奈酚通过 SRC/ERK/CREB 通路下调 MMP2 和 MMP9 抑制类风湿关节炎的发展。
Chin J Integr Med. 2024 Apr;30(4):299-310. doi: 10.1007/s11655-023-3753-6. Epub 2024 Jan 12.
3
Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway.西红花苷元异鼠李素通过 MAPK/mTOR 信号通路抑制胃腺癌细胞的进展。
Sci Rep. 2023 Aug 3;13(1):12607. doi: 10.1038/s41598-023-39627-z.